SCHEMBL24920125

SCHEMBL24920125

COC(=O)Cn1nc(C(N)=O)c2ccc(OCC#N)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ HPGD P15428 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ SLC2A1 P11166 1/20 0.38
▸ PSEN1 P49768 2/20 0.37
▸ PSEN2 P49810 2/20 0.37
▸ APH1B Q8WW43 2/20 0.37
▸ NCSTN Q92542 2/20 0.37
▸ APH1A Q96BI3 2/20 0.37
▸ PSENEN Q9NZ42 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ CFD P00746 9/20 0.36
▸ ALDH2 P05091 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19208522 0.90 GPR119 (0.39) KDM4EALDH1A1HPGDSMN1; SMN2KMT2A
SCHEMBL29781770 0.88 SLC2A1 (0.40) KDM4EALDH1A1HPGDSMN1; SMN2KMT2A
SCHEMBL19208780 0.88 SLC2A1 (0.40) KDM4EALDH1A1HPGDSMN1; SMN2KMT2A
SCHEMBL19236963 0.87 PSEN1 (0.42) ALDH1A1KMT2ALMNASLC2A1PSEN1
SCHEMBL24920126 0.79 KDM4E (0.44) KDM4EALDH1A1HPGDSMN1; SMN2KMT2A
SCHEMBL13844068 0.72 DYRK1A (0.47) DYRK1AKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL12678074 0.72 ALDH1A1 (0.43) DYRK1AKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL19208841 0.72 TDP1 (0.44) KDM4EALDH1A1SMN1; SMN2HTTMAPT
SCHEMBL29781573 0.71 CFD (0.46) CFD
SCHEMBL19208651 0.71 CFD (0.46) CFD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11559515-B2 Indole compounds and analogues thereof BIOCRYST PHARMACEUTICALS, INC. (US) 2023-01-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11559515-B2 Indole compounds and analogues thereof C5, IDO1, IDO2 DYRK1A 3052/4885KDM4E 3768/4885ALDH1A1 1113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback